glp-1 health risks Medications: Everything You Need to Know glp-1 risks GLP-1 medications are
Description
Wegovy and Ozempic-maker Novo Nordisk has been particularly aggressive in suing compounders, though it recently made nice and teamed up with one of its biggest telehealth competitors, Hims & Hers
Yes, since both contain the same semaglutide
Secondary outcomes included site-specific cancer risks stratified by GLP-1 agonist type and treatment duration
The most severe side effects were seen with diarrhea
The Frequent Traveler: Transporting injectable pens often requires cooler bags and refrigeration
doi: 10.1038/nrendo.2012.140 22 NauckMAQuastDRWefersJMeierJJ
